Highlights from this Publication

“… we showed that the smartphone reader used by patients at home performed as good as the point-of-care Quantum Blue reader in the hospital. Additional benefits of the home test include a reduction of the burden on hospital laboratory resources and a more patient-friendly sampling technique…”

“…We found sufficient agreement between the home-used lateral flow test and the hospital-based ELISA test in the lower ranges of calprotectin to use this new test for
telemonitoring of patients with asymptomatic IBD…”

“…Calprotectin home monitoring with a smartphone fits perfectly in the current spirit of the times and is another important step towards patient-centered care…”